Abstract
Coronary artery disease (CAD) is a significant global health problem, contributing to significant morbidity and mortality. Percutaneous coronary intervention (PCI) is an efficient therapy for treating CAD, but it carries the risk of iatrogenic endothelial injury, which contributes to vessel inflammation and induction of in-stent restenosis. Therefore, developing novel methods for enhancing re-endothelialization after PCI is highly needed. Endothelial progenitor cells (EPCs) can differentiate into mature endothelial cells, and cell therapy with EPC may offer a novel way for accelerating reendothelialization. In this review paper, we aimed to briefly describe EPCs and highlight their potential therapeutic roles in in-stent re-stenosis and endothelial injury.
Keywords: Coronary heart disease, endothelial cell, endothelial progenitor cell, endothelium injury, percutaneous coronary intervention, in-stent restenosis.
Current Stem Cell Research & Therapy
Title:Endothelial Progenitor Cells and In-stent Restenosis
Volume: 10 Issue: 4
Author(s): Bu-Yun Xu, Mei-Xiang Xiang and Jian-an Wang
Affiliation:
Keywords: Coronary heart disease, endothelial cell, endothelial progenitor cell, endothelium injury, percutaneous coronary intervention, in-stent restenosis.
Abstract: Coronary artery disease (CAD) is a significant global health problem, contributing to significant morbidity and mortality. Percutaneous coronary intervention (PCI) is an efficient therapy for treating CAD, but it carries the risk of iatrogenic endothelial injury, which contributes to vessel inflammation and induction of in-stent restenosis. Therefore, developing novel methods for enhancing re-endothelialization after PCI is highly needed. Endothelial progenitor cells (EPCs) can differentiate into mature endothelial cells, and cell therapy with EPC may offer a novel way for accelerating reendothelialization. In this review paper, we aimed to briefly describe EPCs and highlight their potential therapeutic roles in in-stent re-stenosis and endothelial injury.
Export Options
About this article
Cite this article as:
Xu Bu-Yun, Xiang Mei-Xiang and Wang Jian-an, Endothelial Progenitor Cells and In-stent Restenosis, Current Stem Cell Research & Therapy 2015; 10 (4) . https://dx.doi.org/10.2174/1574888X10666150204150430
DOI https://dx.doi.org/10.2174/1574888X10666150204150430 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry An Overview on COVID-19 and its Effect on Cardiovascular Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Cardiovascular Risk Factors and Macrovascular and Microvascular Complications of Diabetes
Current Drug Targets Enhanced Selectivity Screening of GPCR Ligands Using a Label-Free Cell Based Assay Technology
Combinatorial Chemistry & High Throughput Screening Multiple Lipid-lowering Treatment in Pediatric Patients with Hyperlipidemia
Medicinal Chemistry Deep Inspiration Breath-hold (DIBH) Technique to Reduce Cardiac Radiation Dose in the Management of Breast Cancer
Current Cancer Therapy Reviews Editorial [Hot Topic:Role of Food and Nutritional Factors in Metabolic Syndrome X,Cancer and Cardiovascular Diseases (Guest Editor: Undurti N. Das)]
Current Nutrition & Food Science Exercise Prescription for Post-Menopausal Women with Obesity
Current Women`s Health Reviews Vascular Endothelin and Hypertension - From Receptors to Medicine
Current Hypertension Reviews New Strategies and Biological Agents in the Treatment of Autoimmune Inflammatory Diseases. Progress and Challenges
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Human PON Promoters: From Similarity to Prediction of Polymorphic Positions within Transcription Factor Elements
Mini-Reviews in Medicinal Chemistry The Many Antithrombotic Actions of Nitric Oxide
Current Drug Targets Influence of Leptin on Immunity
Current Immunology Reviews (Discontinued) Selective Serotonin Re-Uptake Inhibitors and Hyponatremia in Acutely Medically-Ill Inpatients
Current Drug Safety Ivabradine: A Current Overview
Current Clinical Pharmacology Incretin-Based Therapies in Patients with Type 2 Diabetes
Current Drug Therapy Platelet Turnover in Atherothrombotic Disease
Current Pharmaceutical Design DASH Dietary Pattern: A Treatment for Non-communicable Diseases
Current Hypertension Reviews Liquid Chromatography Coupled to Electrochemical Detection and Mass Spectrometry for the Determination of Phenolic Compounds in Food and Beverages
Current Analytical Chemistry The Effectiveness of Nurse- and Pharmacist-Directed Care in Diabetes Disease Management:A Narrative Review
Current Diabetes Reviews